Following the exciting 2022 in-person Communiqué Awards, we are pleased to offer our readers a selection of case studies that ...
PMEA returned on 21 November at the Sheraton Grand in London to recognise excellence within pharmaceutical marketing. The ...
Pfizer’s Hympavzi (marstacimab) has been approved by the European Commission (EC) to treat haemophilia A or B in adult and ...
Communicating complex medical information has the potential to overwhelm patients and caregivers. The key is blending ...
Patient recruitment and retention company, Innovative Trials, was shortlisted as a finalist in the PME Award for its ...
In 2022, there is a renewed focus on diversity, equity and inclusion (DE&I) in the workplace. But for DE&I to be successful, ...
What makes a story powerful? Storytelling is becoming more critical than ever. In medical publications, healthcare providers ...
Biogen and Eisai’s Alzheimer’s disease (AD) drug has been recommended by the European Medicines Agency’s human medicines ...
New Environmental, Social and Governance (ESG) regulations coming into force across the EU in 2025 stand to shift how ...
Katie Rose (Consultant – Market Access), Maria Dimitrova (Consultant – HTA) and Samantha Gillard (Director – HTA) provide an ...
In a clinical trial, the current status for participants, indicating at what stage the trial is. Before a trial begins, participants will be being recruited, and during a trial, participants will be ...
We are one of the largest Independent CROs in India with a scientific edge, technical skills and better foresight for BA BE Studies & Clinical trials; with an objective of becoming a catalyst for ...